Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Laura, Fernández Landó"'
Autor:
Ildiko Lingvay, Ofri Mosenzon, Katelyn Brown, Xuewei Cui, Ciara O’Neill, Laura Fernández Landó, Hiren Patel
Publikováno v:
Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-10 (2023)
Abstract Background Tirzepatide, a once-weekly glucose-dependent insulinotropic polypeptide/ glucagon-like peptide-1 receptor agonist, is approved in the United States, Europe and Japan for the treatment of type 2 diabetes. Across the SURPASS-1 to -5
Externí odkaz:
https://doaj.org/article/4cc69da4844c471b9f872fa4f70bc5ba
Autor:
Adie Viljoen, Kevin M. Pantalone, Rodolfo J. Galindo, Xuewei Cui, Ruth Huh, Andrea Hemmingway, Laura Fernández Landó, Hiren Patel
Publikováno v:
Diabetes Therapy. 14:925-936
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a00c0cd804e97a157701e5a714a26f45
https://doi.org/10.1007/s13300-023-01398-1
https://doi.org/10.1007/s13300-023-01398-1
Autor:
Sue D. Pedersen, Francesco Giorgino, Guillermo Umpierrez, Vivian T. Thieu, Angel Rodríguez, Claudia Nicolay, Laura Fernández Landó, Chrisanthi A. Karanikas, Jacek Kiljanski
Publikováno v:
Diabetes, Obesity and Metabolism.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6076ec503b5f7765d1e84ee0030e9bd0
https://doi.org/10.1111/dom.15140
https://doi.org/10.1111/dom.15140
Autor:
Amalia Gastaldelli, Kenneth Cusi, Laura Fernández Landó, Ross Bray, Bram Brouwers, Ángel Rodríguez, Markus Menzen
Publikováno v:
Diabetologie und Stoffwechsel.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f142966d566987eead6ff1620184896
https://doi.org/10.1055/s-0043-1767866
https://doi.org/10.1055/s-0043-1767866
Autor:
Adie Viljoen, Kevin Pantalone, Rodolfo Galindo, Xuewei Cui, Ruth Huh, Laura Fernández Landó, Hirenkumar Patel, Baptist Gallwitz
Publikováno v:
Diabetologie und Stoffwechsel.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56d1e345e208ffac5996ee7a8d016f8b
https://doi.org/10.1055/s-0043-1767992
https://doi.org/10.1055/s-0043-1767992
Autor:
Katelyn Brown, Laura Fernández Landó, Brandon Bergman, Melissa K. Thomas, Bing Liu, Clare Lee, Michael A. Nauck
Publikováno v:
Diabetologie und Stoffwechsel.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ff18aa6179e1782401c42d4ba56baa7
https://doi.org/10.1055/s-0043-1767867
https://doi.org/10.1055/s-0043-1767867
Autor:
Amalia Gastaldelli, Kenneth Cusi, Laura Fernández Landó, Ross Bray, Bram Brouwers, Ángel Rodríguez
Publikováno v:
The Lancet Diabetes & Endocrinology. 10:393-406
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1bf62f4f188207f73b4c695c0386d313
https://doi.org/10.1016/s2213-8587(22)00070-5
https://doi.org/10.1016/s2213-8587(22)00070-5
Autor:
Tadej, Battelino, Richard M, Bergenstal, Angel, Rodríguez, Laura, Fernández Landó, Ross, Bray, Zhentao, Tong, Katelyn, Brown
Publikováno v:
The Lancet Diabetes & Endocrinology. 10:407-417
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist under development for the treatment of type 2 diabetes. In this study, we used continuous glucose monitoring (CGM) to compare the 24 h glucose p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c72d226c78efdabe929084019109a73
https://doi.org/10.1016/s2213-8587(22)00077-8
https://doi.org/10.1016/s2213-8587(22)00077-8
Publikováno v:
Journal of the Endocrine Society. 7
Context Tirzepatide is a glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist approved for treatment of type 2 diabetes (T2D). SURPASS-1, a phase 3 trial of tirzepatide monotherapy in people with early T2D, enable
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56397aa88b37cf81fdbe7c6ec76837b9
https://doi.org/10.1210/jendso/bvad056
https://doi.org/10.1210/jendso/bvad056
Autor:
Laura Fernández Landó, Juan P. Frias, Xuewei Cui, Brandon K. Bergman, Federico C. Perez Manghi, Bing Liu, Melanie J. Davies, Katelyn Brown, Julio Rosenstock
Publikováno v:
New England Journal of Medicine. 385:503-515
Background Tirzepatide is a dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) receptor agonist that is under development for the treatment of type 2 dia...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::056a63bf9c86c79b4b1ed10cebf1dcde
https://doi.org/10.1056/nejmoa2107519
https://doi.org/10.1056/nejmoa2107519